A rare tumor: Syringocystadenocarcinoma papilliferum

Dermatologic Surgery

Volumn 37, Issue 2, 2011, Pages 271-274

  Aydin, Osman Enver ^a   Sahin, Baris ^b   Ozkan, Heval Selman ^a   Gore, Oya ^c  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Mus State Hospital   (Turkey)

^c Buca Seyfi Demirsoy Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER SIZE; CANCER SURGERY; CASE REPORT; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCALP TUMOR; SPLIT THICKNESS SKIN GRAFT; SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM; ULCER;

AGED; CYSTADENOCARCINOMA, PAPILLARY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; SCALP; SKIN NEOPLASMS; SYRINGOMA;

EID: 79951917315     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01872.x     Document Type: Article

References (15)

1. Park SH, Shin YM, Shin DH, et al,. Syringocystadenocarcinoma papilliferum: a case report. J Korean Med Sci 2007; 22: 762-5.
2. Chi CC, Tsai RY, Wang SH., Syringocystadenocarcinoma papilliferum: successfully treated with Mohs micrographic surgery. Dermatol Surg 2004; 30: 468-71.
3. Stokes JH., A clinico-pathologic study of an unusual cutaneous neoplasm combining naevus syringadenomatosus papilliferus and a granuloma. J Cutan Dis 1917; 35: 411-9.
4. Dissanayake RV, Salm R., Sweat-gland carcinomas: prognosis related to histological type. Histopathology 1980; 4: 445.
5. Seco Navedo MA, Fresno Forcelledo M, Orduna Domingo A, et al,. Syringocystadenoma papilliferum with malignant evolution: presentation of a case. Ann Dermatol Venereol 1982; 109: 685-9.
6. Numata M, Hosoe S, Itoh N, et al,. Syringadenocarcinoma papilliferum. J Cutan Pathol 1985; 12: 3-7. (Pubitemid 15198295)
7. Bondi R, Urso C., Syringocystadenocarcinoma papilliferum. Histopathology 1996; 28: 475-7. (Pubitemid 26157699)
8. Ishida-Yamamoto A, Sato K, Wada T, et al,. Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol 2001; 45: 755-9.
9. Arai Y, Kusakabe H, Kiyokane K., A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum. J Dermatol 2003; 30: 146-50. (Pubitemid 36368116)
10. Woestenborghs H, Van Evken P, Dans A., Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report. Histopathology 2006; 48: 869-70. (Pubitemid 43800948)
11. Hoekzema R, Leenarts MF, Nijhuis EW., Syringocystadenocarcinoma papilliferum in a linear nevus verrucosus. J Cutan Pathol 2011; 38: 246-50.
12. Langner C, Ott A., Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin. APMIS 2009; 117: 148-50.
13. Sroa N, Sroa N, Zirwas M., Syringocystadenocarcinoma papilliferum. Dermatol Surg 2010; 36: 261-3.
14. Plaza JA, Ortega PF, Stockman DL, Suster S., Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 2010; 37: 403-10.
15. Böni R, Xin H, Hohl D, et al,. Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol 2001; 23: 87-9.